I think the market response will be proportional to how much retail press an approval gets. If the NYT has a lead article highlighting the approval and does a good job explaining the science and its results there will be a huge surge of new buyers.
Yes……my thoughts are that how the heck can u obtain patient data without first selling them Blar?? You contradict yourself. And if you are going to ask for a price prediction then define the time frame. Finally just how much is the first oral approved ALZ drug worth? Sales and profits will determine company value.